ResearcherUniversity of MissouriActive in the last 2 years

Nan Lyu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5088159809. Sources: OpenAlex.

Their work

Papers: 5 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 25

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 5

First-line nanoparticle polymeric micellar paclitaxel with gemcitabine in metastatic pancreatic cancer: a single-arm, prospective, and exploratory study. Co-author DOI 10.1093/gastro/goag034 ↗
Mechanistic and functional characterization of ABTB2 as a novel target for pancreatic cancer therapy. Co-author DOI 10.1016/j.omton.2025.201080 ↗
[Short-term outcomes of the TRIANGLE operation after neoadjuvant chemotherapy in locally advanced pancreatic cancer]. Co-author DOI 10.3760/cma.j.cn112139-20230615-000234 ↗
A novel role of TGFBI in macrophage polarization and macrophage-induced pancreatic cancer growth and therapeutic resistance. First author DOI 10.1016/j.canlet.2023.216457 ↗
Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study. Co-author DOI 10.1007/s00423-019-01766-1 ↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kuirong Jiang · 3 shared papers, 2019–2026 · strength 0.50
- Paper First-line nanoparticle polymeric micellar paclitaxel with gemcitabine in metastatic pancreatic cancer: a single-arm, p… DOI 10.1093/gastro/goag034 ↗
- Paper [Short-term outcomes of the TRIANGLE operation after neoadjuvant chemotherapy in locally advanced pancreatic cancer]. DOI 10.3760/cma.j.cn112139-20230615-000234 ↗
- Paper Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study. DOI 10.1007/s00423-019-01766-1 ↗
Min Tu · 2 shared papers, 2024–2026 · strength 0.42
- Paper First-line nanoparticle polymeric micellar paclitaxel with gemcitabine in metastatic pancreatic cancer: a single-arm, p… DOI 10.1093/gastro/goag034 ↗
- Paper [Short-term outcomes of the TRIANGLE operation after neoadjuvant chemotherapy in locally advanced pancreatic cancer]. DOI 10.3760/cma.j.cn112139-20230615-000234 ↗
Eric T. Kimchi · 2 shared papers, 2023–2025 · strength 0.41
- Paper Mechanistic and functional characterization of ABTB2 as a novel target for pancreatic cancer therapy. DOI 10.1016/j.omton.2025.201080 ↗
- Paper A novel role of TGFBI in macrophage polarization and macrophage-induced pancreatic cancer growth and therapeutic resist… DOI 10.1016/j.canlet.2023.216457 ↗
Guangfu Li · 2 shared papers, 2023–2025 · strength 0.41
- Paper Mechanistic and functional characterization of ABTB2 as a novel target for pancreatic cancer therapy. DOI 10.1016/j.omton.2025.201080 ↗
- Paper A novel role of TGFBI in macrophage polarization and macrophage-induced pancreatic cancer growth and therapeutic resist… DOI 10.1016/j.canlet.2023.216457 ↗
Kun Cheng · 2 shared papers, 2023–2025 · strength 0.41
- Paper Mechanistic and functional characterization of ABTB2 as a novel target for pancreatic cancer therapy. DOI 10.1016/j.omton.2025.201080 ↗
- Paper A novel role of TGFBI in macrophage polarization and macrophage-induced pancreatic cancer growth and therapeutic resist… DOI 10.1016/j.canlet.2023.216457 ↗
Kai Zhang · 2 shared papers, 2019–2024 · strength 0.26
- Paper [Short-term outcomes of the TRIANGLE operation after neoadjuvant chemotherapy in locally advanced pancreatic cancer]. DOI 10.3760/cma.j.cn112139-20230615-000234 ↗
- Paper Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study. DOI 10.1007/s00423-019-01766-1 ↗
Jishu Wei · 2 shared papers, 2019–2024 · strength 0.26
- Paper [Short-term outcomes of the TRIANGLE operation after neoadjuvant chemotherapy in locally advanced pancreatic cancer]. DOI 10.3760/cma.j.cn112139-20230615-000234 ↗
- Paper Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study. DOI 10.1007/s00423-019-01766-1 ↗
Yi Miao · 2 shared papers, 2019–2024 · strength 0.26
- Paper [Short-term outcomes of the TRIANGLE operation after neoadjuvant chemotherapy in locally advanced pancreatic cancer]. DOI 10.3760/cma.j.cn112139-20230615-000234 ↗
- Paper Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study. DOI 10.1007/s00423-019-01766-1 ↗
Ernest Ramsay Camp · 1 shared paper, 2025 · strength 0.24
- Paper Mechanistic and functional characterization of ABTB2 as a novel target for pancreatic cancer therapy. DOI 10.1016/j.omton.2025.201080 ↗
Xinjian Liu · 1 shared paper, 2025 · strength 0.24
- Paper Mechanistic and functional characterization of ABTB2 as a novel target for pancreatic cancer therapy. DOI 10.1016/j.omton.2025.201080 ↗
Yi Miao · 1 shared paper, 2025 · strength 0.24
- Paper Mechanistic and functional characterization of ABTB2 as a novel target for pancreatic cancer therapy. DOI 10.1016/j.omton.2025.201080 ↗
Olamide Tosin Olaoba · 1 shared paper, 2025 · strength 0.24
- Paper Mechanistic and functional characterization of ABTB2 as a novel target for pancreatic cancer therapy. DOI 10.1016/j.omton.2025.201080 ↗
Jiangtao Yin · 1 shared paper, 2024 · strength 0.18
- Paper [Short-term outcomes of the TRIANGLE operation after neoadjuvant chemotherapy in locally advanced pancreatic cancer]. DOI 10.3760/cma.j.cn112139-20230615-000234 ↗
Yang Feng Wu · 1 shared paper, 2024 · strength 0.18
- Paper [Short-term outcomes of the TRIANGLE operation after neoadjuvant chemotherapy in locally advanced pancreatic cancer]. DOI 10.3760/cma.j.cn112139-20230615-000234 ↗
Chunhua Xi · 1 shared paper, 2024 · strength 0.18
- Paper [Short-term outcomes of the TRIANGLE operation after neoadjuvant chemotherapy in locally advanced pancreatic cancer]. DOI 10.3760/cma.j.cn112139-20230615-000234 ↗
Di Xu · 1 shared paper, 2024 · strength 0.18
- Paper [Short-term outcomes of the TRIANGLE operation after neoadjuvant chemotherapy in locally advanced pancreatic cancer]. DOI 10.3760/cma.j.cn112139-20230615-000234 ↗
Pengfei Wu · 1 shared paper, 2024 · strength 0.18
- Paper [Short-term outcomes of the TRIANGLE operation after neoadjuvant chemotherapy in locally advanced pancreatic cancer]. DOI 10.3760/cma.j.cn112139-20230615-000234 ↗
Jing Zhou · 1 shared paper, 2023 · strength 0.18
- Paper A novel role of TGFBI in macrophage polarization and macrophage-induced pancreatic cancer growth and therapeutic resist… DOI 10.1016/j.canlet.2023.216457 ↗
Ming Jun Yang · 1 shared paper, 2023 · strength 0.18
- Paper A novel role of TGFBI in macrophage polarization and macrophage-induced pancreatic cancer growth and therapeutic resist… DOI 10.1016/j.canlet.2023.216457 ↗
Lingdi Yin · 1 shared paper, 2019 · strength 0.08
- Paper Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study. DOI 10.1007/s00423-019-01766-1 ↗
Wentao Gao · 1 shared paper, 2019 · strength 0.08
- Paper Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study. DOI 10.1007/s00423-019-01766-1 ↗
Yunpeng Peng · 1 shared paper, 2019 · strength 0.08
- Paper Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study. DOI 10.1007/s00423-019-01766-1 ↗
Hao Gao · 1 shared paper, 2019 · strength 0.08
- Paper Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study. DOI 10.1007/s00423-019-01766-1 ↗
Guangfu Wang · 1 shared paper, 2019 · strength 0.08
- Paper Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study. DOI 10.1007/s00423-019-01766-1 ↗
Junli Wu · 1 shared paper, 2019 · strength 0.08
- Paper Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study. DOI 10.1007/s00423-019-01766-1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.